COVID-19 IN MEXICO: PREPARING FOR FUTURE PANDEMICS

Abstract

The COVID-19 pandemic from 2019 onwards leaves us with an imperative lesson: we must be vigilant and ready to act once a new pandemic occurs. We must have scientific teams ready to develop basic and applied research at a rapid pace; trained and qualified medical teams to act immediately, with all personal and institutional security measures at their disposal; governments determined to put aside political differences to achieve the common welfare and a population informed about prevention measures, ready to abide by the indications of experts. We review the scientific opinions (and the lack of it) from the pandemics administrators in Mexico, in morning press conferences of the Mexican president, in evening press conferences by the pandemics manager and in written and electronic media, and we talk about how this is expected to be achieved in the short term, to avoid the many mistakes that have been done so far.
 
 Peer Review History: 
 Received: 1 May 2021; Revised: 15 June; Accepted: 29 June, Available online: 15 July 2021
 Academic Editor: Ahmad Najib, Universitas Muslim Indonesia, Makassar, Indonesia, ahmad.najib@umi.ac.id
 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. 
 Received file: Reviewer's Comments:
 Average Peer review marks at initial stage: 5.5/10
 Average Peer review marks at publication stage: 7.0/10
 Reviewer(s) detail:
 Prof. Dr. Hassan A.H. Al-Shamahy, Sana'a University, Yemen, shmahe@yemen.net.ye
 Dr. Bilge Ahsen KARA, Ankara Gazi Mustafa Kemal Hospital, Turkey, ahsndkyc@gmail.com
 Dr. Muhammad Zahid Iqbal, AIMST University, Malaysia, drmmziqbal@gmail.com
 Dr. Vanina Doris Edo’o, University of Yaounde I, Yaounde, Cameroun, vanina_edoo@yahoo.com
 Similar Articles:
 THE RISKS AND ADVANTAGES OF ANTI-DIABETES THERAPY IN THE POSITIVE COVID-19 PATIENT
 SUDANESE EXPERIENCE OF HERBAL FORMULAS USED DURING COVID-19 INFECTION